Sylvain Ricard
Impact in
-
- Hormonal Regulation and Hypertension
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
Papers in
-
- Hormonal Regulation and Hypertension 10
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
-
- Renin-Angiotensin System Studies 9
- Co-authors
- Odette PoirierFrançois CambienDominique ArveilerLaurence TiretFlorent SoubrierAlun EvansGérald LucJean‐Pierre Cambou
- Journals
- Journal of Hypertension (3 papers)Hypertension (3 papers)Human Mutation (2 papers)Immunology (1 paper)Diabetes (1 paper)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Sylvain Ricard
31 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Endocrinology, Diabetes and Metabolism 1.8k
- Cardiology and Cardiovascular Medicine 2.3k
- Pharmacology 628
- Genetics 690
- Neurology 283
Countries citing papers authored by Sylvain Ricard
This map shows the geographic impact of Sylvain Ricard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Ricard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Ricard more than expected).
Fields of papers citing papers by Sylvain Ricard
This network shows the impact of papers produced by Sylvain Ricard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Ricard. The network helps show where Sylvain Ricard may publish in the future.
Co-authors
The 25 scholars most cited alongside Sylvain Ricard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Blood pressure control in hypertensive patients with stable coronary heart disease]. | 2005 | 1 |
| 2 | 2004 | 1 | |
| 3 | 2004 | 79 | |
| 4 | 2004 | 85 | |
| 5 | 2003 | 12 | |
| 6 | 2003 | 21 | |
| 7 | 2003 | 224 | |
| 8 | 2003 | 7 | |
| 9 | 2002 | 30 | |
| 10 | 2000 | 9 | |
| 11 | 1999 | 124 | |
| 12 | 1998 | 69 | |
| 13 | 1996 | 5 | |
| 14 | 1996 | 10 | |
| 15 | 1996 | 221 | |
| 16 | 1995 | 255 | |
| 17 | 1994 | 356 | |
| 18 | 1994 | 1 | |
| 19 | 1993 | 56 | |
| 20 | Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction Hit paper breakdown → | 1992 | 1552 |
About Sylvain Ricard
Sylvain Ricard is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Genetics, Biochemistry and Surgery, having authored 31 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (10 papers), Renin-Angiotensin System Studies (9 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers), Genetic Associations and Epidemiology (5 papers), Lipoproteins and Cardiovascular Health (5 papers), Alzheimer's disease research and treatments (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Cardiology and Cardiovascular Medicine (2.3k citations), Pharmacology (628 citations), Genetics (690 citations) and Neurology (283 citations). Sylvain Ricard has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Odette Poirier, François Cambien, Dominique Arveiler, Laurence Tiret, Florent Soubrier, Alun Evans, Gérald Luc, Jean‐Pierre Cambou, L. Bara and Jean‐Marie Bard. Their work appears in journals such as Journal of Hypertension, Hypertension, Human Mutation, Immunology and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.